Reuters – 3SBio to Go Private in $340M Deal

Chinese biotechnology firm 3SBio Inc. said it agreed to be bought by Decade Sunshine Ltd. for about $340 million, Reuters reported. The offer of $15.40 per American Depositary Shares is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.

(Reuters) – Chinese biotechnology firm 3SBio Inc said it agreed to be bought by Decade Sunshine Ltd for about $340 million.

The offer of $15.40 per American Depositary Shares (ADS) is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.

3SBio Chief Executive Jing Lou had offered to take the company private for up to $15 per ADS, or about $331 million, last September.

Leave a Reply

PE HUB Community

Join the 12515 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget